| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |